<i>upd3</i> loss-of-function mutations suppress the synthetic lethal phenotype of <i>Gpdh1</i>^{<i>A10/B18</i>}<i>; Ldh</i>^<i>16/17</i> double mutants. by Madhulika Rai (4352803)

RNAi targeting of <i>upd3</i> expression in muscle of <i>Gpdh1; Ldh</i> double mutant partially suppresses the developmental arrest phenotype. by Madhulika Rai (4352803)

GRADE judgements. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Basic characteristics of the included studies. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

The data of meta-analysis. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Risk of bias. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Overall risk of bias assessment. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Funnel plot of VO_2Peak inclusion studies. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Analysis of subgroups. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

Subjects:

Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

Subjects:

Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

Subjects:

Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients. by Ningning Wang (560944)

Subjects:

The values of angiotensin II by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

Subjects:

Individual stability values for different gait events under various conditions. by Hyung Suk Yang (20442438)

Subjects:

General characterization of T2DM patients and healthy controls. by Ningning Wang (560944)

Subjects:

Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups. by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. by Ningning Wang (560944)

Subjects: